Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-25 @ 2:38 AM
NCT ID:
NCT03833934
Eligibility Criteria:
Inclusion Criteria:
* Men or women older than 18 years at the time of consent.
* Demonstration of having advanced ALK positive NSCLC.
* Systemic progression (not CNS only progression) within the past 30 days while receiving a next generation ALK TKI.
* Patient must not have started a new line of therapy before signing the informed consent form.
* Willingness to provide a blood specimen prior to the initiation of a new line of treatment.
* Willing to provide clinical and medical information to the study team as required.
* Ability to read, write and communicate in English.
* Ability to sign a web-based informed consent form.
Exclusion Criteria:
* Participants who are unable to provide informed consent.
* Participants who are 18 years of age or younger.
* Participants who are unable to comply with the study procedures.
* Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements.
* Participants who have previously enrolled to the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03833934
Study Brief:
Protocol Section:
NCT03833934